Diphenylamine-substituted salicylthiazole derivatives and related compounds such as phosphotyrosine phosphatase 1B (PTP1B) inhibitor for use as blood glucose lowering active agents in the treatment of diabetes

摘要

The invention therefore relates to compounds of the formula I in which the variables are as defined in the specification, to pharmaceutical compositions containing them and to their use for therapeutically lowering blood glucose levels.